Literature DB >> 21613616

Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice.

Daniel B Rainbow1, Carolyn Moule, Heather I Fraser, Jan Clark, Sarah K Howlett, Oliver Burren, Mikkel Christensen, Val Moody, Charles A Steward, Javid P Mohammed, Michael E Fusakio, Emma L Masteller, Erik B Finger, J P Houchins, Dieter Naf, Frank Koentgen, William M Ridgway, John A Todd, Jeffrey A Bluestone, Laurence B Peterson, Jochen Mattner, Linda S Wicker.   

Abstract

We have previously proposed that sequence variation of the CD101 gene between NOD and C57BL/6 mice accounts for the protection from type 1 diabetes (T1D) provided by the insulin-dependent diabetes susceptibility region 10 (Idd10), a <1 Mb region on mouse chromosome 3. In this study, we provide further support for the hypothesis that Cd101 is Idd10 using haplotype and expression analyses of novel Idd10 congenic strains coupled to the development of a CD101 knockout mouse. Susceptibility to T1D was correlated with genotype-dependent CD101 expression on multiple cell subsets, including Foxp3(+) regulatory CD4(+) T cells, CD11c(+) dendritic cells, and Gr1(+) myeloid cells. The correlation of CD101 expression on immune cells from four independent Idd10 haplotypes with the development of T1D supports the identity of Cd101 as Idd10. Because CD101 has been associated with regulatory T and Ag presentation cell functions, our results provide a further link between immune regulation and susceptibility to T1D.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613616      PMCID: PMC3128927          DOI: 10.4049/jimmunol.1003523

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  The mosaic structure of variation in the laboratory mouse genome.

Authors:  Claire M Wade; Edward J Kulbokas; Andrew W Kirby; Michael C Zody; James C Mullikin; Eric S Lander; Kerstin Lindblad-Toh; Mark J Daly
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

3.  The generic genome browser: a building block for a model organism system database.

Authors:  Lincoln D Stein; Christopher Mungall; ShengQiang Shu; Michael Caudy; Marco Mangone; Allen Day; Elizabeth Nickerson; Jason E Stajich; Todd W Harris; Adrian Arva; Suzanna Lewis
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

4.  p126 (CDw101), a costimulatory molecule preferentially expressed on mucosal T lymphocytes.

Authors:  G J Russell; C M Parker; A Sood; E Mizoguchi; E C Ebert; A K Bhan; M B Brenner
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

5.  Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity.

Authors:  Javid P Mohammed; Michael E Fusakio; Daniel B Rainbow; Carolyn Moule; Heather I Fraser; Jan Clark; John A Todd; Laurence B Peterson; Paul B Savage; Marsha Wills-Karp; William M Ridgway; Linda S Wicker; Jochen Mattner
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

6.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

Authors:  F Schwenk; U Baron; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

7.  Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouse.

Authors:  P A Lyons; N Armitage; C J Lord; M S Phillips; J A Todd; L B Peterson; L S Wicker
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

8.  Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse.

Authors:  Tim Wiltshire; Mathew T Pletcher; Serge Batalov; S Whitney Barnes; Lisa M Tarantino; Michael P Cooke; Hua Wu; Kevin Smylie; Andrey Santrosyan; Neal G Copeland; Nancy A Jenkins; Francis Kalush; Richard J Mural; Richard J Glynne; Steve A Kay; Mark D Adams; Colin F Fletcher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-28       Impact factor: 11.205

9.  Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD mice.

Authors:  Carlos Penha-Gonçalves; Carolyn Moule; Luc J Smink; Joanna Howson; Simon Gregory; Jane Rogers; Paul A Lyons; Joseph J Suttie; Christopher J Lord; Laurence B Peterson; John A Todd; Linda S Wicker
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

10.  V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies.

Authors:  A Rivas; C L Ruegg; J Zeitung; R Laus; R Warnke; C Benike; E G Engleman
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

View more
  18 in total

Review 1.  Autoimmunity in 2011.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

2.  Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity.

Authors:  Javid P Mohammed; Michael E Fusakio; Daniel B Rainbow; Carolyn Moule; Heather I Fraser; Jan Clark; John A Todd; Laurence B Peterson; Paul B Savage; Marsha Wills-Karp; William M Ridgway; Linda S Wicker; Jochen Mattner
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

3.  Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection.

Authors:  William H Hudson; Julia Gensheimer; Masao Hashimoto; Andreas Wieland; Rajesh M Valanparambil; Peng Li; Jian-Xin Lin; Bogumila T Konieczny; Se Jin Im; Gordon J Freeman; Warren J Leonard; Haydn T Kissick; Rafi Ahmed
Journal:  Immunity       Date:  2019-12-03       Impact factor: 31.745

4.  B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.

Authors:  Jun Sik Lee; Lisa Scandiuzzi; Anjana Ray; Joyce Wei; Kimberly A Hofmeyer; Yael M Abadi; P'ng Loke; Juan Lin; Jianda Yuan; David V Serreze; James P Allison; Xingxing Zang
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

Review 5.  B7-H4 as a protective shield for pancreatic islet beta cells.

Authors:  Annika C Sun; Dawei Ou; Dan S Luciani; Garth L Warnock
Journal:  World J Diabetes       Date:  2014-12-15

6.  CD16+ monocytes give rise to CD103+RALDH2+TCF4+ dendritic cells with unique transcriptional and immunological features.

Authors:  Vanessa Sue Wacleche; Amélie Cattin; Jean-Philippe Goulet; Dominique Gauchat; Annie Gosselin; Aurélie Cleret-Buhot; Yuwei Zhang; Cécile L Tremblay; Jean-Pierre Routy; Petronela Ancuta
Journal:  Blood Adv       Date:  2018-11-13

7.  Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.

Authors:  Hélène Bour-Jordan; Heather L Thompson; Jennifer R Giampaolo; Dan Davini; Wendy Rosenthal; Jeffrey A Bluestone
Journal:  J Autoimmun       Date:  2013-07-12       Impact factor: 7.094

8.  CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions.

Authors:  Laura E Richert-Spuhler; Corinne M Mar; Paurvi Shinde; Feinan Wu; Ting Hong; Evan Greene; Sharon Hou; Katherine Thomas; Raphael Gottardo; Nelly Mugo; Guy de Bruyn; Connie Celum; Jared M Baeten; Jairam R Lingappa; Jennifer M Lund
Journal:  Cell Rep Med       Date:  2021-06-15

9.  The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes.

Authors:  Charles A Steward; Jose M Gonzalez; Steve Trevanion; Dan Sheppard; Giselle Kerry; James G R Gilbert; Linda S Wicker; Jane Rogers; Jennifer L Harrow
Journal:  Database (Oxford)       Date:  2013-05-31       Impact factor: 3.451

10.  Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes.

Authors:  Nora M Kochupurakkal; Annie J Kruger; Sudipta Tripathi; Bing Zhu; La Tonya Adams; Daniel B Rainbow; Aldo Rossini; Dale L Greiner; Mohamed H Sayegh; Linda S Wicker; Indira Guleria
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.